LONDON, March 24, 2023 /PRNewswire/ Dechert LLP has announced that Sam Kay, one of the leading private equity fund lawyers in the UK, will be joining the firm as a partner in the financial
Increasingly, the FDA is asking drugmakers to remove unproven uses from older drugs that haven't delivered on early results. And drugmakers seeking accelerated approvals are facing tougher hurdles.
Expedited drug approvals slowed this year as the Food and Drug Administration s contentious accelerated pathway came under new scrutiny from Congress, government watchdogs and some of the agency s own leaders.
Speedier drug approvals hit slowdown as FDA faces scrutiny | iNFOnews | Thompson-Okanagan s News Source infotel.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from infotel.ca Daily Mail and Mail on Sunday newspapers.